Teradyne (NASDAQ:TER – Get Free Report) had its price objective increased by analysts at The Goldman Sachs Group from $107.00 to $118.00 in a report issued on Friday, Benzinga reports. The firm currently has a “neutral” rating on the stock. The Goldman Sachs Group’s price target would suggest a potential upside of 3.07% from the […]